- New cholesterol, obesity guidelines give greater role to statins, call for more research into weight-loss drugs
- Study: Pharmavite's CholestOff found to lower LDL
- ROUNDTABLE: Pharmacy’s future in sync with technology
- Walgreens expands preventive healthcare services to Maryland market
- New guidelines: Half of population between 40 and 75 years old should be on statin regimen
WILMINGTON, Del. With September marked as National Cholesterol Education Month, drug maker AstraZeneca is using the occasion to push lifestyles that promote low cholesterol, the Anglo-Swedish company said.
AstraZeneca, which markets the cholesterol-lowering drug Crestor (rosuvastatin calcium), is pushing such habits as a healthy diet and exercise as ways to keep cholesterol down. According to the American Heart Association, 102 million Americans ages 20 years and older have borderline-high or high cholesterol.
“The patient-doctor partnership is one of the most critical relationships you can have, and National Cholesterol Education Month can be a reminder to see your doctor, talk about your cholesterol numbers and target goal, and understand how to assess your cardiovascular risk,” physician and founder of the Texas-based Legacy Heart Center Waenard Miller said in a statement on behalf of AstraZeneca.